Detalles de la búsqueda
1.
Efficacy of CAR T-Cell Therapy is Not Impaired by Previous Bispecific Antibody Treatment in Large B-Cell Lymphoma.
Blood
; 2024 04 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-38657242
2.
The role of chimeric antigen receptor T cells targeting more than one antigen in the treatment of B-cell malignancies.
Br J Haematol
; 204(5): 1649-1659, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38362778
3.
The academic point-of-care anti-CD19 chimeric antigen receptor T-cell product varnimcabtagene autoleucel (ARI-0001 cells) shows efficacy and safety in the treatment of relapsed/refractory B-cell non-Hodgkin lymphoma.
Br J Haematol
; 204(2): 525-533, 2024 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-37905734
4.
Endothelial Activation and Stress Index in adults undergoing allogeneic hematopoietic cell transplantation with post-transplant cyclophosphamide-based prophylaxis.
Cytotherapy
; 26(1): 73-80, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-37952139
5.
Infection epidemiology in relation to different therapy phases in patients with haematological malignancies receiving CAR T-cell therapy.
Eur J Haematol
; 112(3): 371-378, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-37879842
6.
Current outcomes of SARS-CoV-2 Omicron variant infection in high-risk haematological patients treated early with antivirals.
J Antimicrob Chemother
; 78(6): 1454-1459, 2023 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37051877
7.
Evaluation of cell collection efficiency in non-mobilized adult donors for autologous chimeric antigen receptor T-cell manufacturing.
Vox Sang
; 118(3): 217-222, 2023 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-36516201
8.
A national service for delivering CD19 CAR-Tin large B-cell lymphoma - The UK real-world experience.
Br J Haematol
; 198(3): 492-502, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35485402
9.
Results of ARI-0001 CART19 cell therapy in patients with relapsed/refractory CD19-positive acute lymphoblastic leukemia with isolated extramedullary disease.
Am J Hematol
; 97(6): 731-739, 2022 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35253928
10.
Quantitative PCR Is Faster, More Objective, and More Reliable Than Immunohistochemistry for the Diagnosis of Cytomegalovirus Gastrointestinal Disease in Allogeneic Stem Cell Transplantation.
Biol Blood Marrow Transplant
; 25(11): 2281-2286, 2019 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31325586
11.
Deleterious Effect of Steroids on Cytomegalovirus Infection Rate after Allogeneic Stem Cell Transplantation Depends on Pretransplant Cytomegalovirus Serostatus of Donors and Recipients.
Biol Blood Marrow Transplant
; 24(10): 2088-2093, 2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-29753162
12.
Increased Serum Levels of N-terminal pro-B-type Natriuretic Peptide (NT-proBNP) in Mobilized Healthy Donors with G-CSF: A Cohort Study.
Transfus Med Rev
; 38(2): 150824, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38569349
13.
Treatment outcomes in patients with large B-cell lymphoma after progression to chimeric antigen receptor T-cell therapy.
Hemasphere
; 8(5): e62, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38774657
14.
Biomarkers of Efficacy and Safety of the Academic BCMA-CART ARI0002h for the Treatment of Refractory Multiple Myeloma.
Clin Cancer Res
; 30(10): 2085-2096, 2024 May 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-38466644
15.
Effect of CD34+ Cell Dose on the Outcomes of Allogeneic Stem Cell Transplantation with Post-Transplantation Cyclophosphamide.
Transplant Cell Ther
; 29(3): 181.e1-181.e10, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36526259
16.
Incidence, risk factors, and impact of early cardiac toxicity after allogeneic hematopoietic cell transplant.
Blood Adv
; 7(10): 2018-2031, 2023 05 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-36453637
17.
Anakinra for Refractory Cytokine Release Syndrome or Immune Effector Cell-Associated Neurotoxicity Syndrome after Chimeric Antigen Receptor T Cell Therapy.
Transplant Cell Ther
; 29(7): 430-437, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37031746
18.
Role of allogeneic hematopoietic cell transplant for relapsed/refractory aggressive B-cell lymphomas in the CART era.
Bone Marrow Transplant
; 58(6): 673-679, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36918682
19.
Practical aspects of chimeric antigen receptor T-cell administration: From commercial to point-of-care manufacturing.
Front Immunol
; 13: 1005457, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36238283
20.
T cells isolated from G-CSF-treated multiple myeloma patients are suitable for the generation of BCMA-directed CAR-T cells.
Mol Ther Methods Clin Dev
; 26: 207-223, 2022 Sep 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35859694